PARAGANGLIOMAS

Clinical trials for PARAGANGLIOMAS explained in plain language.

Never miss a new study

Get alerted when new PARAGANGLIOMAS trials appear

Sign up with your email to follow new studies for PARAGANGLIOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New radioactive drug targets Hard-to-Treat gut and adrenal tumors

Disease control Recruiting now

This study tests a new radioactive drug, [212Pb]VMT-alpha-NET, in people with advanced gastrointestinal neuroendocrine tumors or pheochromocytoma/paragangliomas that have already been treated with radiation therapy. The drug is designed to attach to a protein on the surface of th…

Matched conditions: PARAGANGLIOMAS

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jul 01, 2026 00:00 UTC

PARAGANGLIOMAS

Get alerted when new PARAGANGLIOMAS trials appear

New radioactive drug targets Hard-to-Treat gut and adrenal tumors